Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tong Ren Tang Technologies Co Ltd

+ Add to Watchlist

1666:HK

9.690 HKD 0.020 0.21%

As of 03:01:04 ET on 03/05/2015.

Snapshot for Tong Ren Tang Technologies Co Ltd (1666)

Open: 9.640 Day's Range: 9.610 - 9.810 Volume: 381,414
Previous Close: 9.710 52wk Range: 9.060 - 13.700 1-Yr Rtn: -26.94%

Stock Chart for 1666

No chart data available.
  • 1666:HK 9.690
  • 1D
  • 1M
  • 1Y
9.710
Interactive 1666 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1666

Current P/E Ratio (ttm) 13.4940
Estimated P/E(12/2014) 21.7452
Relative P/E vs. HSI 1.3095
Earnings Per Share (CNY) (ttm) 0.5801
Est. EPS (CNY) (12/2014) 0.3600
Est. PEG Ratio -
Market Cap (M HKD) 12,410.80
Shares Outstanding (M) 628.70
30 Day Average Volume 892,017
Price/Book (mrq) 1.4721
Price/Sale (ttm) 1.9570
Dividend Indicated Gross Yield 1.61%
Cash Dividend (CNY) 0.1125
Dividend Ex-Date 06/17/2014
5 Year Dividend Growth 15.49%
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1666

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 1666

Tong Ren Tang Technologies Company Limited manufactures, distributes, and researches, and develops Chinese patent medicine.

Mei QunChairmanWang QuanVice Chairman
Wang Yu WeiCEO/ManagerGong QinExecutive Director
More Company Profile & Key Executives for 1666

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil